
Sign up to save your podcasts
Or
Mark McKenna, chairman and CEO at Mirador Therapeutics, speaks with Venrock partner Nimish Shah to discuss his most recent role at Prometheus Biosciences and the beginning of his new company, Mirador. McKenna shares a behind-the-scenes look into leading Prometheus during its acquisition by Merck, why he started Mirador Therapeutics, advice for other CEOs, what he values in a team and more.
4.8
6262 ratings
Mark McKenna, chairman and CEO at Mirador Therapeutics, speaks with Venrock partner Nimish Shah to discuss his most recent role at Prometheus Biosciences and the beginning of his new company, Mirador. McKenna shares a behind-the-scenes look into leading Prometheus during its acquisition by Merck, why he started Mirador Therapeutics, advice for other CEOs, what he values in a team and more.
1,282 Listeners
2,161 Listeners
1,040 Listeners
976 Listeners
1,795 Listeners
2,287 Listeners
3,991 Listeners
121 Listeners
317 Listeners
5,955 Listeners
1,543 Listeners
30 Listeners
144 Listeners
18 Listeners
50 Listeners